disopyramide has been researched along with Fatigue Syndrome, Chronic in 3 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conclude that chronic fatigue syndrome is associated with neurally mediated hypotension and that its symptoms may be improved in a subset of patients by therapy directed at this abnormal cardiovascular reflex." | 1.29 | The relationship between neurally mediated hypotension and the chronic fatigue syndrome. ( Bou-Holaigah, I; Calkins, H; Kan, J; Rowe, PC, 1995) |
| "Neurally mediated hypotension is now recognised as a common cause of otherwise unexplained recurrent syncope, but has not been reported in association with chronic fatigue." | 1.29 | Is neurally mediated hypotension an unrecognised cause of chronic fatigue? ( Bou-Holaigah, I; Calkins, H; Kan, JS; Rowe, PC, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bou-Holaigah, I | 2 |
| Rowe, PC | 2 |
| Kan, J | 1 |
| Calkins, H | 2 |
| Walden, RJ | 1 |
| Kan, JS | 1 |
3 other studies available for disopyramide and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
The relationship between neurally mediated hypotension and the chronic fatigue syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Di | 1995 |
Is neurally mediated hypotension an unrecognised cause of chronic fatigue?
Topics: Atenolol; Disopyramide; Fatigue Syndrome, Chronic; Humans; Hypotension; Tilt-Table Test | 1995 |
Is neurally mediated hypotension an unrecognised cause of chronic fatigue?
Topics: Adolescent; Atenolol; Autonomic Nervous System Diseases; Blood Pressure; Child; Disopyramide; Fatigu | 1995 |